Somers Allyson E, Hinton Robert B, Pilipenko Valentina, Miller Erin, Ware Stephanie M
University of Cincinnati College of Medicine, Cincinnati, Ohio.
Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Am J Med Genet A. 2016 Jul;170(7):1786-90. doi: 10.1002/ajmg.a.37668. Epub 2016 Apr 26.
Marfan syndrome (MFS) and Loeys-Dietz syndrome (LDS) are genetic disorders that affect connective tissue as a result of dysregulated TGF-β signaling. MFS is most frequently caused by mutations in FBN1 whereas Loeys-Dietz syndrome results from mutations in TGFBR1 or TGFBR2. There is substantial inter- and intra-familial phenotypic variability among these disorders, suggesting the presence of genetic modifiers. Previously, a polymorphism in the TGFβR1 protein termed the TFGBR16A allele was found to be overrepresented in patients with MFS and was identified as a low penetrance allele with suggestion as a possible modifier. To further investigate the importance of this variant, a retrospective review of genetic and phenotypic findings was conducted for 335 patients evaluated for suspicion of MFS or related disorders. In patients with a diagnosis of MFS, the presence of the TFGBR16A allele was not associated with phenotypic differences. Similarly, careful phenotyping of patients who carried the TFGBR16A allele but did not have MFS did not identify an altered frequency of specific connective tissue features. In this small cohort, the results did not reach significance to identify the TFGBR16A allele as a major modifier for aortic dilation, ectopia lentis, or systemic features associated with MFS or other connective tissue disorders. © 2016 Wiley Periodicals, Inc.
马凡综合征(MFS)和洛伊迪茨综合征(LDS)是由于转化生长因子-β(TGF-β)信号失调而影响结缔组织的遗传性疾病。马凡综合征最常见的病因是FBN1基因突变,而洛伊迪茨综合征则是由TGFBR1或TGFBR2基因突变引起的。这些疾病在家族间和家族内存在显著的表型变异,提示存在遗传修饰因子。此前,发现转化生长因子β受体1(TGFβR1)蛋白中的一种多态性,即TFGBR16A等位基因,在马凡综合征患者中过度表达,并被确定为一种低外显率等位基因,有可能是一种修饰因子。为了进一步研究该变异的重要性,对335例疑似马凡综合征或相关疾病的患者进行了遗传和表型结果的回顾性分析。在确诊为马凡综合征的患者中,TFGBR16A等位基因的存在与表型差异无关。同样,对携带TFGBR16A等位基因但未患马凡综合征的患者进行仔细的表型分析,也未发现特定结缔组织特征的频率改变。在这个小队列中,结果未达到显著水平,无法将TFGBR16A等位基因确定为主动脉扩张、晶状体异位或与马凡综合征或其他结缔组织疾病相关的全身特征的主要修饰因子。© 2016威利期刊公司